(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding chronic kidney disease

Anthropic Finalizing $15 Billion Pre-IPO Credit Facility
23:29

Broadcom Slides After AI Chip Forecast Underwhelms Investors
20:57

Chevron to Invest $7 Billion to Double Its Venezuelan Output
23:39